Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Plexin C1 is a cell-surface receptor prominently expressed in the nervous, immune, and cardiovascular systems, where it functions in repulsive signal transduction by binding ligands such as semaphorin 7A and certain viral proteins (e.g., A39R)[1][2]. It features a unique extracellular domain structure with two PSI and four IPT domains, and the semaphorin-binding Sema domain, distinguishing it from other plexins[2]. Upon ligand binding, Plexin C1 dimerizes, enabling activation of its intracellular GAP activity and downstream signaling pathways responsible for cell migration, immune regulation, and axon guidance[1][2]. This receptor's structure-function relationship is particularly relevant for disease processes involving cell migration, immune modulation, and viral pathogenesis, making it an emerging therapeutic target, though drug development is still in preliminary stages.
Competitive inhibition or modulation of semaphorin binding; Dimerization-dependent activation leading to intracellular signaling changes; Viral mimicry (by viral proteins such as A39R which structurally resembles endogenous ligand and activates or blocks PlexinC1 signaling).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plexin C1 (PlexinC1).